Company News in the Life Science Industry

»

Reset 

FDA Advisory Committee Votes on Zynquista™ (sotagliflozin) as Treatment for Adults With Type 1 Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee Meeting for Sotagliflozin in Type 1 Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

Muhammad Yasser Darkazally, M.D. is recognized by Continental Who's Who

TULSA, Okla., Jan. 17, 2019 /PRNewswire/ -- Muhammad Yasser Darkazally, M.D. is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Internal Medicine in recognition of his role as an Internist at Saint Francis Hospitalists.

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019

Taiho Oncology and Servier Present Data on LONSURF® (trifluridine/tipiracil) at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)

PRINCETON, N.J., Jan. 17, 2019 /PRNewswire/ -- Taiho Oncology, Inc. and Servier announced today that the safety and efficacy in patients with gastrectomy from the global Phase 3 TAGS trial evaluating LONSURF(®) in patients with previously treated metastatic gastric cancer (mGC) are consistent... Read more ››

By: PR Newswire Association LLC. - 18 Jan 2019
Related companies:  Taiho Ventures, LLC

The healthcare business analytics market is projected to reach USD 50.5 billion by 2024 from USD 14.0 billion in 2019, at a CAGR of 28.3%

NEW YORK, Jan. 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019

Brain Tumor Funders' Collaborative Announces $3 Million in Grants

CHICAGO, Jan. 17, 2019 /PRNewswire/ -- The Brain Tumor Funders' Collaborative (BTFC) - six funders of brain tumor research - just announced $3 million in grants to four multi-institutional teams of researchers and clinicians studying immunotherapy in primary brain tumors.

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019

HEXO Corp. announces results of annual general meeting

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

Avivagen Announces CEO Letter to Shareholders

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Avivagen Inc.

ContraFect Announces Additional $2.3 Million in Funding from CARB-X to Support Gram-Negative Lysin Program

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Contrafect Corporation

Zafgen Announces Positive Results for Second Cohort of Phase 2 Clinical Trial of ZGN-1061

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Zafgen Inc.

AVROBIO, Inc. Announces Analyst and Investor Event and Upcoming Clinical Data Presentations at WORLDSymposium 2019

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Avrobio Inc.

HEXO to begin trading on the NYSE American

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer Patients

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  IMV Inc.

Lexicon Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Sotagliflozin New Drug Application for the Treatment of Type 1 Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Moleculin Announces Dr. James L. Abbruzzese, Chief of Medical Oncology Division at Duke University, Joins Science Advisory Board

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Moleculin Biotech, Inc.

ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  ProMIS Neurosciences, Inc.

Ossur Hf : Q4&FY 2018 Results - Conference call Tuesday 5 February at 9:00 CET

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Össur Nordic AB | Össur Germany | Össur Americas, Inc.

American Postal Workers Union Health Plan Selects Inovalon ONE® Platform

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Inovalon

Canopy Rivers Appoints Former OMERS Venture Capital Specialist as President

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies